TXNIP Regulates Peripheral Glucose Metabolism in Humans
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. METHODS AND FINDINGS: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. CONCLUSIONS: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes (A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test. (B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH−), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.](https://figures.cochat.ai/paper-figures/ca9ef16bc19d42259bbcc36f2b7c4340/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-2.jpg)

![Figure 4 Insulin-Mediated Glucose Uptake Versus TXNIP Expression This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].](https://figures.cochat.ai/paper-figures/c969253506d74789b5b972b212cc68b2/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-4.jpg)

![Figure 6 Pattern of Genetic Variation at the TXNIP Locus Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D′ values were calculated with 95% confidence intervals. D′ plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D′ with high logarithm of odds (LOD) score, while white indicates low D′ with low LOD score, and blue indicates high D′ with low LOD score.](https://figures.cochat.ai/paper-figures/1e45333953bb4d3999d14146d7c357ce/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-6.jpg)
![Figure 7 Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM (A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery. (B) Role of TXNIP in glucose toxicity in the β-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic β-cell is initially able to compensate by secreting more insulin, but eventually the β-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic β-cell TXNIP expression, which can induce apoptosis [40]. The loss of β-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.](https://figures.cochat.ai/paper-figures/00021f5e308f4c0db15afac10c663543/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA Isolation, Target Preparation, and Hybridization RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 1×
“Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D9 values were calculated with 95% confidence intervals.”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (http://www.”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764 · cited 1×
“To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30].”
MethodBase-Calling of Automated Sequencer Traces Using Phred. I. Accuracy Assessment
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,967 · cited 1×
“Each base was called using the PHRED software package [19,20], and quality scores were assigned.”
MethodBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · cited 1×
“]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on…”
MethodInfluential
Research works printed but not linked: 56
- Kahn, 1994, Diabetes, 43, 1066
- Eriksson, 1989, N Engl J Med, 321, 337
- Lyssenko, 2005, Diabetes, 54, 166
- Martin, 1992, Lancet, 340, 925
- Groop, 1996, Diabetes, 45, 1585
- Roden, 2005, Int J Obes, 2, S111
- Shulman, 2000, J Clin Invest, 106, 171
- Eriksson, 1990, Diabetologia, 33, 526
- Ling, 2004, J Clin Invest, 114, 1518
- Poulsen, 2005, Diabetes, 54, 275
- Chomczynski, 1987, Anal Biochem, 162, 156
- Golub, 1999, Science, 286, 531
- Wabitsch, 2001, Int J Obes Relat Metab Disord, 25, 8
- Al-Khalili, 2003, Cell Mol Life Sci, 60, 991
- Rubin, 1977, J Biol Chem, 252, 3554
- Al-Khalili, 2003, Biochem Biophys Res Commun, 307, 127
- Yoshioka, 2004, Circulation, 109, 2581
- Mootha, 2003, Nat Genet, 34, 267
- Ewing, 1998, Genome Res, 8, 186
- Ewing, 1998, Genome Res, 8, 175
- Staden, 1996, Mol Biotechnol, 5, 233
- de Bakker, 2005, Nat Genet, 37, 1217
- Florez, 2004, Diabetes, 53, 3313
- Purcell, 2003, Bioinformatics, 19, 149
- McClintick, 2006, BMC Bioinformatics, 7, 49
- Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
- Patti, 2003, Proc Natl Acad Sci U S A, 100, 8466
- Yechoor, 2002, Proc Natl Acad Sci U S A, 99, 10587
- Yechoor, 2004, Proc Natl Acad Sci U S A, 101, 16525
- Zeger, 1986, Biometrics, 42, 121
- Zandbergen, 2005, Biochem J, 392, 313
- Phan, 2004, Nature, 432, 635
- Lee, 2003, Science, 302, 453
- Nishiyama, 1999, J Biol Chem, 274, 21645
- Shalev, 2002, Endocrinology, 143, 3695
- Hirota, 2002, J Biol Chem, 277, 44244
- Kobayashi, 2003, Kidney Int, 64, 1632
- Schulze, 2004, J Biol Chem, 279, 30369
- Hansen, 2004, Biochem Biophys Res Commun, 323, 685
- Minn, 2005, Endocrinology, 146, 2397
- Wolfrum, 2003, Proc Natl Acad Sci U S A, 100, 11624
- Elbein, 1999, Diabetes, 48, 1175
- Vionnet, 2000, Am J Hum Genet, 67, 1470
- Donnelly, 2004, J Nutr, 134, 1475
- Sheth, 2005, J Lipid Res, 46, 123
- Brownlee, 2001, Nature, 414, 813
- Houstis, 2006, Nature, 440, 944
- Petersen, 2003, Science, 300, 1140
- Wang, 2006, Oncogene, 25, 1903
- Han, 2003, Oncogene, 22, 4035
- DeFronzo, 2004, Med Clin North Am, 88
- Bonner-Weir, 2000, Trends Endocrinol Metab, 11, 375
- Poitout, 2002, Endocrinology, 143, 339
- Zierath, 2003, Best Pract Res Clin Endocrinol Metab, 17, 385
- Barrett, 2005, Bioinformatics, 21, 263
- Furuyama, 2000, Biochem J, 349, 629
Cited by
Items 401–499 of 499
Xiao, Z., Xu, Q., WANG, H., ZHOU, X., ZHU, Y., Bao, C., CHEN, L., ZHANG, P., Lin, M. T., Ji, C., et al. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.028075 · Cited by 5
Maeda, K., Yamada, H., Munetsuna, E., Fujii, R., Yamazaki, M., Ando, Y., Mizuno, G., Tsuboi, Y., Ishikawa, H., Ohashi, K., et al. (2023) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000791 · Cited by 4
Anticipation of Precision Diabetes and Promise of Integrative Multi-Omics
Liu, C., & Sun, Y. V. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.011 · Cited by 4
Sieber‐Frank, J., Stark, H., Kalteis, S., Prigge, E., Köhler, R. M., Andresen, C., Henkel, T. O., Casari, G., Schubert, T., Fischl, W., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4212 · Cited by 4
Widjaja, J., Chu, Y., Wang, J., Hong, J., Zhu, X., & Yao, L. (2023) · BioMed Research International · doi:10.1155/2023/9563359 · Cited by 4
Harley, G., & Mount, P. F. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103741 · Cited by 4
Generative AI Uncovers Novel Chrebp/Txnip Axis Inhibitors with Potential Anti-inflammatory Activity
Qayyum, N., Khan, A. W., Haseeb, M., Ahmed, B., Farooq, M., Manan, A., Kim, E., & Choi, S. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02172 · Cited by 3
Amino acid deprivation induces TXNIP expression by NRF2 downregulation
Ahn, S. H., Jang, S., Kim, Y. J., Kim, G., Park, K. S., Park, I., & Jin, H. (2023) · IUBMB Life · doi:10.1002/iub.2792 · Cited by 3
“12,13 Based on these findings, it is reasonable to hypothesize that TXNIP expression induced by AA deprivation may affect tumor suppression of NSCLC by inhibiting glucose metabolism.”
BackgroundTxnip regulates the Oct4-mediated pluripotency circuitry via metabolic changes upon differentiation
Kwak, S., Song, C. L., Cho, Y. S., Choi, I., Byun, J., Jung, H., & Lee, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05161-y · Cited by 3
“Txnip is also known as an important regulator of glucose and lipid metabolism [29], suggesting that Txnip loss may modulate metabolic changes associated the entry and exit of pluripotency.”
BackgroundA compendium of noncoding RNAs as biomarkers in Type 2 Diabetes Mellitus
Manjusha, A. S., Mendonca, A., Manikandan, T., Sateesh, D., Swaminathan, A. R., Parameshwaran, D., Gupta, M., & Sujatha, S. (2025) · Journal of Pharmaceutical and Biomedical Analysis Open · doi:10.1016/j.jpbao.2025.100057 · Cited by 6
Maimaiti, S., Dagnell, M., Coppo, L., & Arnér, E. S. J. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.035 · Cited by 3
Acetylation reader BRD4-driven TXNIP transcription enhances NLRP3 inflammasome activation in PCOS
Weng, Y., Zhang, Y., Dong, W., Zhu, Z., Xiang, Z., Yan, G., Wang, H., Wen, Y., Liu, M., Wang, D., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05925-0 · Cited by 4
Kumar, A., & Sharmila, D. J. S. (2015) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-015-0113-z · Cited by 3
Zhang, L., Song, Z., Zhong, S., & Cui, Z. (2024) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2024.111739 · Cited by 4
Park, K. H., Lee, H., Kim, H.-C., Choi, I., Han, S., & Kang, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713584 · Cited by 3
Maeda, K., Fujii, R., Yamada, H., Munetsuna, E., Yamazaki, M., Ando, Y., Mizuno, G., Ishikawa, H., Ohashi, K., Tsuboi, Y., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0629 · Cited by 4
Peshdary, V., Gagnon, A., Landry, A., Ma, L., & Sorisky, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.09.009 · Cited by 3
Potter, P. G. W., Washer, S. J., Jeffries, A. R., Holley, J. E., Gutowski, N. J., Dempster, E. L., & Beall, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671724 · Cited by 4
“LG and RLG shared similar DE patterns (Figure 2B) and importantly TXNIP, regulated by glucose (20), was significantly downregulated in both LG (log2 fold-”
BackgroundSearching for Causality of Knocking Out Txnip
Davis, R. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.165654 · Cited by 3
Sklifasovskaya, A. P., Blagonravov, M. L., Мухамедовна, А. М., & Goryachev, V. A. (2023) · Pathophysiology · doi:10.3390/pathophysiology30020021 · Cited by 2
“(2007) found that an inverse correlation between TXNIP expression and the rate of insulin-dependent glucose uptake in skeletal muscles is associated with a higher risk of type 2 DM in humans [15].”
BackgroundDağdeviren, S., Hoang, M. F., Wang, J., Goldberger, T., Yu, A., Blair, S. J., Benoit, J. C., Ricci-Blair, E. M., Melnik, V. Y., Kim, B., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110214 · Cited by 2
“The TXNIP protein also participates in the regulation of peripheral glucose metabolism in humans (18).”
Self-citationTAS1R3 Regulates GTPase Signaling in Human Skeletal Muscle Cells for Glucose Uptake
Hoolachan, J. M., Balakrishnan, R., Merz, K. E., Thurmond, D. C., & Veluthakal, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010103 · Cited by 2
Thioredoxin 1 Suppresses TXNIP-Driven Control of Glucose Metabolism in Human Cells
Maimaiti, S., Dagnell, M., Coppo, L., Zhao, W., Geserick, P., Kappert, K., & Arnér, E. S. J. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864261421616 · Cited by 3
“Consistent with this, silencing TXNIP has been shown to improve glucose uptake in human adipocytes, skeletal muscle, and mouse embryonic fi broblasts (Huy et al., 2018; Parikh et al., 2007).”
The interplay between the thioredoxin system and hypoxia-related factors in cancer
Bramatti, I., Branco, V., & Carvalho, C. M. L. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.040 · Cited by 2
Aldoghachi, A. F., Yanagisawa, D., Arrozi, A. P., Bakar, Z. H. A., Taguchi, H., Ishigaki, S., Morino, K., & Tooyama, I. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149392 · Cited by 2
Fedotkina, O., Jain, R., Prasad, R. B., Luk, A. O. Y., García‐Ramírez, M., Özgümüş, T., Cherviakova, L., Khalimon, N., Svietleisha, T., Buldenko, T., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858049 · Cited by 3
“Additionally, we analyzed expression of Txnip—a thioredoxin interaction protein ascribed a pathogenic role in diabetes and related complications, whose expression is strongly up-regulated by glucose in normal physiology (Parikh et al., 2007).”
MethodSelf-citationXue, T., Wang, X., Hu, Y. C., Cheng, Y., Li, H., Shi, Y., Wang, L., Yin, D., & Cui, D. (2022) · Brain Sciences · doi:10.3390/brainsci12101395 · Cited by 3
“TXNIP could be induced by a variety of cellular stress that results in enhanced oxidative stress, such as UV light, H2O2, heat shock [8], high glucose [9], and NMDAR (N-methyl-D-aspartic acid receptor) hypofunction [10].”
BackgroundKhalifa, A. K., Abdelrahim, D. S., Mekawy, D. M., Hamed, R. M. R., Mohamed, W. R., Ramadan, N. M., Wael, M., Ellackany, R., Albadawi, E. A., & Osman, W. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38932 · Cited by 3
TXNIP is a Mediator of ER Stress-Induced β-Cell Inflammation and Apoptosis: A Dissertation
Oslowski, C. M. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/mj81-rb58 · Cited by 2
Identification of Cuts-specific Myogenic Marker Genes in Hanwoo by DNA Microarray
Lee, E. J., Shin, Y.-M., Lee, H. J., Yoon, D., Chun, T., Lee, Y. S., & Choi, I. (2010) · Journal of Animal Science and Technology · doi:10.5187/jast.2010.52.4.329 · Cited by 2
Shalev, A. (2016) · eLife · doi:10.7554/elife.21263 · Cited by 2
“However, too much TXNIP can detrimentally affect how the body manages its glucose levels (referred to as glucose homeostasis) in a number of ways (Minn et al., 2005; Parikh et al., 2007; Chutkow et al., 2008; Xu et al., 2013).”
BackgroundMcGarry, S., Kover, K. L., & Luca, F. D. (2024) · Journal of Bone Metabolism · doi:10.11005/jbm.2024.31.3.209 · Cited by 2
“[31] High glucose enhances Txnip expression in cultured renal proximal tubule cell lines,[31] in glomerular mesangial cells,[32] and in breast-cancer-derived cells.”
BackgroundNeuroprotection and Neuroregeneration in Alzheimer's Disease
Sugaya, K., Youdim, M. B. H., Nordberg, A. K., & Rao, K. S. J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/864138 · Cited by 2
Targeting the Metabolic Syndrome and Type 2 Diabetes by Preventing Inflammation
Ardestani, A. D., Shu, L., & Maedler, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00019-x · Cited by 1
Dou, X. N., Wei, F., Zhang, J., Tian, C. C., Fu, L., Jiang, S. S., Lu, J. X., & Zhang, G. H. (2023) · Revista Brasileira de Zootecnia · doi:10.37496/rbz5220220029 · Cited by 1
Revisiting Caloric Restriction as Therapeutic Strategy for Metabolic Syndrome, T2DM and Obesity
Nikhra, V. (2018) · Research in Medical & Engineering Sciences · doi:10.31031/rmes.2018.06.000647 · Cited by 1
“CR and TXN system: For regulating glucose metabolism, TXNIP binds and negatively regulates thioredoxin via a di-sulphide bond and inhibits glucose uptake, the effect which is overcome by insulin [20].”
BackgroundRevisiting Caloric Restriction as Therapeutic Strategy for Metabolic Syndrome, T2DM and Obesity
Nikhra, V. (2018) · Interventions in Obesity & Diabetes · doi:10.31031/iod.2018.02.000538 · Cited by 2
Halder, E., Paul, N. C., & Banjerjee, P. K. (2024) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20240841 · Cited by 1
“(43, 44) TXNIP has been shown to play a critical role in glucose and lipid metabolism, and its dysregulation has been linked to abnormal NEFA homeostasis.”
BackgroundOng, K. T. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 2
Cellular Responses to Lactic Acidosis in Human Cancers
Chen, J. L.-Y. (2010) · DukeSpace (Duke University) · Cited by 1
Kempermann, G. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733851922.793550051 · Cited by 1
Cooper, A. W. J. (2013) · PEARL (University of Plymouth) · doi:10.24382/4356
Clarke, K. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Lee, Y., & Kim, J. B. (2013) · Journal of Life Science · doi:10.5352/jls.2013.23.6.825
“성인당뇨라고 알려진 제2형당뇨는 인슐 린저항성과 impaired glucose tolerance가 생기고 결국 이들의 이상증상을 보상할 만큼의 췌장 베타세포에서의 인슐린 분비 가 되지 않을 때 제2형당뇨로 발전하게 된다[8, 20].”
Do mitochondria provide a common link between diabetes and Parkinson's disease?
Timmons, J., Schéele, C., & Wahlestedt, C. (2007) · Practical Diabetes · doi:10.1002/pdi.1136
Energy balance and cancer risk : metabolic and molecular studies
Wheatley, K. E. (2010) · Texas ScholarWorks (Texas Digital Library)
Ye, Z., & Ayer, D. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1683-2_5
“TXNIP also controls peripheral glucose uptake into skeletal muscle [106], hepatic glucose production [19], and glucose toxicity of pancreatic β-cells [15] and, by doing so, contributes to organismal glucose homeostasis.”
BackgroundPhysiological Relevance of Antioxid/Redox Genes; Learning from Genetically Modified Animals
Masutani, H., Yoshihara, E., Masaki, S., Chen, Z., & Yodoi, J. (2012)
brainresponse and glutathione status in rat Diabetes impairs exercise training-associated
Khanna, S., Sen, C. K., Lappalainen, J., Oksala, N., & Laaksonen, D. E. (2015)
Nigris, V. D. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Jackson, M. J. (2014) · Bangor University Research Portal (Bangor University)
O'shea, J., Ayer, D. E., Farrell, A., Sears, R. C., Sabò, A., Amati, B. B., Rahl, P. B., Young, R. A., Eisenman, N., McFerrin, L. G., et al. (2014)
Caillaud, M. B. C. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-11042016-115124 · Cited by 3
Sensors and switches in lipid and glucose metabolism
van Greevenbroek, M. M. J. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282efa4cd
Vitamin D3 Upregulated Protein 1 (VDUP1): Roles in Redox Signaling and Stress-Mediated Diseases
Kim, D., Suh, H., Jung, H., Park, Y. J., & Choi, I. (2012) · Oxidative stress and disease · doi:10.1201/b13714-9
RNAi targeting Caenorhabditis elegans α-arrestins has small or no effects on lifespan
Park, S., Jung, Y., An, S. W. A., Son, H. G., Hwang, W., Lee, D.-Y., Artan, M., Park, H. H., Jeong, D., Lee, Y., et al. (2017) · F1000Research · doi:10.12688/f1000research.12337.1
Carvalho, L. A. D. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2017.tde-22082017-104057 · Cited by 1
RNAi targeting Caenorhabditis elegans α-arrestins has little effect on lifespan
Park, S., Jung, Y., An, S. W. A., Son, H. G., Hwang, W., Lee, D.-Y., Artan, M., Park, H. H., Jeong, D., Lee, Y., et al. (2017) · F1000Research · doi:10.12688/f1000research.12337.4
Lo, A., Holmes, K., Mundt, F., Moorthi, S., Fung, I., Fereshetian, S., Watson, J., Carr, S. A., Mertins, P., & Berger, A. H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.10.030460
Kumar, A., & Sharmila, D. J. S. (2015) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-014-0248-3
“GSE7146 Effect of insulin infusion on human skeletal muscle [7] 6 6 22,215 Sweden”
BackgroundLuftig, M. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736111171.793562500
RNAi targeting Caenorhabditis elegans α-arrestins has little effect on lifespan
Park, S., Jung, Y., An, S. W. A., Son, H. G., Hwang, W., Lee, D.-Y., Artan, M., Park, H. H., Jeong, D., Lee, Y., et al. (2017) · F1000Research · doi:10.12688/f1000research.12337.3
Shaked, M., Ketzinel‐Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2012) · PLoS ONE · doi:10.1371/annotation/23f84cc3-627d-4012-ae6f-f3291b2567d0
Epigenetic mechanisms in cardiovascular diseases
Varadarajan, S., Ushio‐Fukai, M., & Fukai, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00020-7
Paul, N. C., Banjerjee, P. K., & Hossain, M. J. (2023) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20230634
Differential effects of sugar and fat on adipose tissue inflammation
Avequin, T., Lau, K. H., Waldhart, A. N., Guak, H., Dykstra, H., Krawczyk, C. M., & Wu, N. (2023) · iScience · doi:10.1016/j.isci.2023.107163
Biochemical Changes in the Local Onco-Sphere
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_8
Ohmori, I., Ouchida, M., Hada, Y., Uchida, H. A., Toyokuni, S., & Mashimo, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.553187 · Cited by 1
Metabolic control by lipid droplet proteins
Menon, D., Jha, R. M., Nahak, A., & Gandotra, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00002-4
Wang, X., Luo, Z., Han, J., Tian, Q., Jing, R., Dong, A., Li, L., Jia, H., Lv, T., Dang, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3766638/v1
Feng, J., Zhu, Z., Zhou, R., Liu, H., Hu, Z., Wu, F., Wang, H., Yue, J., Zhou, T., Yang, L., et al. (2024) · Epigenomics · doi:10.2217/epi-2023-0449
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179323
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179311
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179329
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179308
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179341
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179335
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179338
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179320
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179314
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179332
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179326
Barkova, O. Y., Krutikova, A. A., & Ларкина, Т. А. (2024) · Genetics and breeding of animals · doi:10.31043/2410-2733-2024-1-31-38
Molinar‐Inglis, O., Wiggins, K. D., Varma, A., Mundo, Z. D. D., Adame, J. A., Cozzo, A. J., Muñoz, O., Le, U.-V., Trinh, D., Garcia, A. C., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112405
“Knockdown and overexpression experiments elegantly demonstrated that lack of TXNIP increases glucose uptake (Parikh et al., 2007).”
Sa, R., Ma, J., Yang, J., Li, D. F., Du, J., Jia, J. C., Li, Z. Y., Huang, N., Lamusi, A., Sha, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624076
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q. L., Wang, A., 沈玉帮, Xu, X., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15179317
Parikh, H. M., Elgzyri, T., Alibegovic, A., Hiscock, N., Ekström, O., Eriksson, K.-F., Vaag, A., Groop, L. C., Ström, K., & Hansson, O. (2021) · Figshare · doi:10.6084/m9.figshare.14131032
Self-citationSa, R., Ma, J., Yang, J., Li, D. F., Du, J., Jia, J. C., Li, Z. Y., Huang, N., Lamusi, A., Sha, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624070
Sa, R., Ma, J., Yang, J., Li, D. F., Du, J., Jia, J. C., Li, Z. Y., Huang, N., Lamusi, A., Sha, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624073
Chaddad, H. (2019) · theses.fr (ABES) · doi:10.70675/e2786a5az288az46d4za2afz98cdafddfe5b · Cited by 2
EVT-701 : targeting electron transport chain complex I as therapeutic approach in cancer
Yolba, R. L. (2021) · theses.fr (ABES) · doi:10.70675/9cadea77z03ccz4a54zb381zf34a432615a5 · Cited by 2
LVAD Therapy Improves Metabolic and Inflammatory State in the Heart
Mury, P., Dagher, O., Noly, P., Ducharme, A., Gramolini, S., Billia, F., & Thorin, É. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101540 · Cited by 1
Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment
Luo, Z., Han, J., Zhong, T., Tian, Q., Ge, W., Liu, Z., Li, X., He, M., Zhou, S., Jia, H., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01780
Agu, P. C., Aja, P. M., Ofor, C. O., Ross, K., & Lu, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1907571
“Consequently, TXNIP-driven in fl ammasome activation has been implicated in conditions such as non-alcoholic steatohepatitis (NASH) (39), insulin resistance (40), atherosclerosis (41, 42), prostatic disease (43), and Cerebrovascular and Neurodegenerative Diseases (44).”
Tan, R., Zhu, H., Wang, X., Wang, J., Li, C., Yang, C., Shi, X., Xiu, W., Xu, W., & Han, C. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154399
Metadata
- Authors
- Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Björnholm, M., Tornqvist, H., Zierath, J. R., Ridderstråle, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C., & Mootha, V. K.
- Affiliations
- Lund University (SE)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Karolinska Institutet (SE)
- Novo Nordisk (Denmark) (DK)
- University of Helsinki (FI)
- Corresponding author
- Groop, Leif C
- Mootha, Vamsi K
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-01
- Volume
- 4
- Issue
- 5
- Pages
- e158
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1858708
- OpenAlex
- W2158951820
- Cited by
- 495
- References
- 57
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 41 · 2022: 35 · 2021: 39 · 2020: 34 · 2019: 22 · 2018: 29 · 2017: 21 · 2016: 29 · 2015: 29 · 2014: 23 · 2013: 28 · 2012: 31
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- American Diabetes Association
- Burroughs Wellcome Fund
- Richard and Susan Smith Family Foundation
- European Commission
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TXNIP, type 2 diabetes, skeletal muscle glucose uptake, peripheral glucose metabolism, insulin signaling, adipocytes, prediabetes, glucose homeostasis, insulin-independent glucose uptake, genetic association
- MeSH terms
- Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Gene Expression Regulation, Homeostasis, Humans, Hypoglycemic Agents, Insulin, Promoter Regions, Genetic, Glucose Clamp Technique, Linkage Disequilibrium, Polymerase Chain Reaction, Adipocytes, Glucose Intolerance, Muscle, Skeletal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Array Analysis, Qb-SNARE Proteins, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.